
CRMS Pharmaceutical Private Limited
About CRMS Pharmaceutical Private Limited
Data last updated:
CRMS Pharmaceutical Private Limited is a private limited company based in Gurugram, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U51909HR2017PTC071697. Its GSTIN is 06AAHCC3100F1ZC (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ritesh Madan and Shefali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No. 11 First Floor Palam Vyapar Kendra Palam Vihar, Gurugram, Haryana, India – 122001.
As per the financials filed for FY 2025, the company reported a revenue of ₹89.89 Lakh. For the same year it recorded a net profit of ₹96,570 (net margin 1.1%) and EBITDA of ₹3.33 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 22% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
CRMS Pharmaceutical Private Limited's registered office is in Gurugram, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressOffice No. 11 First Floor Palam Vyapar Kendra Palam Vihar, Gurugram, Haryana, India – 122001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of CRMS Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of CRMS Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of CRMS Pharmaceutical Private Limited, buy the company report.
Financials of CRMS Pharmaceutical Private Limited
FY 2025 filings availableCRMS Pharmaceutical Private Limited reported revenue of ₹89.89 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.33 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹96,570 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of CRMS Pharmaceutical Private Limited, buy the company report.
Board of directors of CRMS Pharmaceutical Private Limited
CRMS Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritesh Madan | Director | 04 Dec 2017 | 8 Years 11 Months | Current |
| Shefali | Director | 04 Dec 2017 | 8 Years 11 Months | Current |
| Raj Kumari | Director | 04 Dec 2017 | 8 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving CRMS Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for CRMS Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
CRMS Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCC3100F1ZC | Haryana | Active | 13 Jan 2018 |
To see the full GST registrations and return filing status of CRMS Pharmaceutical Private Limited, buy the company report.
Recent activity
CRMS Pharmaceutical Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Subhash Chand Madan ceased to be Director on 02 Dec 2023.
Frequently asked questions
CRMS Pharmaceutical is an active private limited company based in Gurugram, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 December 2017 (9+ years old) and is registered under CIN U51909HR2017PTC071697.
CRMS Pharmaceutical has 3 current directors:
- Ritesh Madan - Director
- Shefali - Director
- Raj Kumari - Director
The latest financial statements of CRMS Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of CRMS Pharmaceutical is 06AAHCC3100F1ZC, registered in Haryana.
The CIN (Corporate Identification Number) of CRMS Pharmaceutical is U51909HR2017PTC071697. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
CRMS Pharmaceutical was incorporated on 04 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Haryana.
Subhash Chand Madan ceased to be Director on 02 Dec 2023. Raj Kumari was appointed as Director on 04 Dec 2017. Ritesh Madan was appointed as Director on 04 Dec 2017. CRMS Pharmaceutical has 4 board changes on record in total.
The registered office of CRMS Pharmaceutical is at Office No. 11 First Floor Palam Vyapar Kendra Palam Vihar, Gurugram, Haryana, India – 122001.
CRMS Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of CRMS Pharmaceutical is compliant as of 28 August 2026. The company is actively filing with the Registrar of Companies.

